KOMIPHARM Trademark

Trademark Overview


On Friday, May 8, 2015, a trademark application was filed for KOMIPHARM with the United States Patent and Trademark Office. The USPTO has given the KOMIPHARM trademark a serial number of 79172263. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 9, 2023. This trademark is owned by Komipharm International Co., Ltd.. The KOMIPHARM trademark is filed in the Pharmaceutical Products category with the following description:

Disinfectants for hygiene purposes; Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Household deodorant; Insecticides; Germicides; Insect repellents; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Anti...
komipharm

General Information


Serial Number79172263
Word MarkKOMIPHARM
Filing DateFriday, May 8, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 9, 2023
Registration Number5084132
Registration DateTuesday, November 22, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2016

Trademark Statements


Goods and ServicesDisinfectants for hygiene purposes; Veterinary preparations, namely, pain relief medication, medication for treatment of intestinal bacteria, antioxidants; Deodorizing preparations for household, commercial or industrial use for pet litter boxes, carpets; Household deodorant; Insecticides; Germicides; Insect repellents; Medicines for veterinary purposes, namely, medicines for treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Antibiotic preparations; Chemotherapeutics; Tumor suppressing agents; Pharmaceutical preparations acting on the central nervous system; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation associated with cancer, the treatment of cancer, the treatment of leukemia and lymphoma, the treatment of metastatic neoplastic diseases, the treatment of brain tumors, cancer stem cell-targeted and drug resistant cancer therapy, the treatment of urogenital cancer and its metastasis; Biological preparations for the treatment of porcine circoviral disease, porcine epidemic diarrhea, transmissible gastroenteritis, rotavirus infection pasteurellosis, pleuropneumoniae, classical swine fever, swine erysipelas, swine mycoplasmoses, akabane disease, pasteurellosis, colibacillosis, bovine ephemeral fever, newcastle disease, infectious bronchitis, low pathogenicity avian influenza, infectious bursal disease, salmonellosis, rabies, canine distemper, infectious canine hepatitis, parvovirus infection, coronavirus infection, leptospirosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKomipharm International Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameKomipharm International Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameKomipharm International Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Monday, March 11, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, February 20, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, February 19, 2024INVALIDATION PROCESSED
Friday, February 9, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 9, 2023CANCELLED SECTION 71
Monday, November 22, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, March 25, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 7, 2017FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 7, 2017FINAL DISPOSITION PROCESSED
Wednesday, February 22, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 22, 2016REGISTERED-PRINCIPAL REGISTER
Friday, September 16, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, September 6, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 17, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 26, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 22, 2016EXAMINER'S AMENDMENT ENTERED
Friday, July 22, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 22, 2016EXAMINERS AMENDMENT E-MAILED
Friday, July 22, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, April 21, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 21, 2016NON-FINAL ACTION E-MAILED
Thursday, April 21, 2016NON-FINAL ACTION WRITTEN
Thursday, April 21, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 21, 2016FINAL REFUSAL E-MAILED
Thursday, April 21, 2016FINAL REFUSAL WRITTEN
Monday, March 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 23, 2016ASSIGNED TO LIE
Thursday, March 10, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 26, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 26, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 9, 2015REFUSAL PROCESSED BY IB
Friday, September 18, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 18, 2015REFUSAL PROCESSED BY MPU
Friday, September 18, 2015APPLICATION FILING RECEIPT MAILED
Thursday, September 17, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 16, 2015NON-FINAL ACTION WRITTEN
Monday, September 14, 2015ASSIGNED TO EXAMINER
Monday, September 14, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 10, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB